Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West pharmaceutical services

ISIN: US9553061055 , WKN: 864330

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Healthcare Stocks We Steer Clear Of

2026-05-11
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 5.8% return has trailed the S&P 500 by 1.9 percentage points.

ALGN vs. WST: Which Stock Is the Better Value Option?

2026-05-11
ALGN vs. WST: Which Stock Is the Better Value Option?

GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning

2026-05-11
GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.

West Pharmaceutical Services, Inc. (WST) Hit a 52 Week High, Can the Run Continue?

2026-05-11
West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum

2026-05-09
Stock performance snapshot and business context West Pharmaceutical Services (WST) has drawn fresh attention after recent share price moves, with the stock last closing at $322.01 and showing double digit total returns over the past year. For readers tracking consistency, the stock shows positive total returns over the past week, month and past 3 months, alongside a reported 1 year total return of 50.448% and a 3 year total return of a 9.823% decline. Over 5 years, total return is described...

AMN Q1 Earnings & Revenues Beat Estimates, Gross Margin Contracts

2026-05-08
AMN Healthcare posts 367% adjusted EPS growth in Q1 as labor disruption demand and staffing gains drive revenues past estimates.

MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up

2026-05-08
McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.

INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves

2026-05-08
Inogen posts higher Q1 revenues and improved gross margin as international portable oxygen demand offsets weaker U.S. sales.

Should You Buy, Sell, or Hold McKesson Before Q4 Earnings?

2026-05-07
MCK heads into Q4 earnings with strength in oncology, GLP-1 demand, and biopharma services, but softer medical-surgical trends may weigh.

Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises

2026-05-07
CLOV posts 62% revenue growth in Q1 as Medicare Advantage membership surges and AI-driven care initiatives boost profitability.